A Double-Blind Placebo Controlled Clinical Trial to Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.
Phase of Trial: Phase III
Latest Information Update: 22 Jun 2011
At a glance
- Drugs Rabeprazole (Primary)
- Indications Asthma; Gastro-oesophageal reflux
- Focus Pharmacodynamics
- 11 Sep 2009 New trial record